i

GlobalSurg-CovidSurg Week: Determining the optimal timing for surgery following SARS-CoV-2 infection – Philippine General Hospital data

PHRR220524-004693

Unspecified

Unspecified

GlobalSurg-CovidSurg Week: Determining the optimal timing for surgery following SARS-CoV-2 infection 

Peri-operative SARS-CoV-2 infection increases postoperative mortality. The aim of this study was to determine the optimal duration of planned delay before surgery in patients who have had SARS-CoV-2 infection. This study will contribute to the international, multicentre, prospective cohort study that included patients undergoing elective or emergency surgery during October 2020. Surgical patients with pre-operative SARS-CoV-2 infection were compared with those without previous SARS-CoV-2 infection. The primary outcome measure was 30-day postoperative mortality. Logistic regression models were used to calculate adjusted 30-day mortality rates stratified by time from diagnosis of SARS-CoV-2 infection to surgery.

Regime Classification Priority
2017 - 2022 Responsive health systems Emerging and re-emerging diseases
Start Date Duration in Months Target Completion Date Actual Completion Date
2022-10-01 12 2023-10-01 2022-12-01

Completed

Institution Classification Region LTO #
Philippine General Hospital None Philippines
Institution Region
Philippine General Hospital Philippines
Name E-Mail Institution and Institution Address
Marie Dione P. Sacdalan maparrenosacdalan@up.edu.ph Philippine General Hospital, Taft Avenue, Ermita, Manila
Name E-Mail Institution and Institution Address
Marie Dione P. Sacdalan maparrenosacdalan@up.edu.ph Philippine General Hospital, Taft Avenue, Manila
Name Expertise Affiliation
Ryle Ong Li General Surgery Philippine General Hospital
Vincent Abad Venida General Surgery Philippine General Hospital
Project Location Institutional Ethics Review Board
Philippine General Hospital Philippine General Hospital Ethics Review Board
Philippine General Hospital Philippine General Hospital Ethics Review Board

COVID19

30 day Post-operative Mortality 

Optimal timing of surgery following SARSCoV2 Infection 

Completed

Clinical Trial

Unspecified

Unspecified

0000-00-00

0000-00-00

300

Unspecified

Unspecified

0000-00-00

  1. The inclusion criteria are:

    • ●  Any operations (elective or emergency) done in an operating theater by a surgeon,

      excluding minor procedures previously defined by Abbott, et. al [7] (see Appendix A).

    • ●  All surgical specialties including: acute care surgery, breast surgery, cardiac surgery, colorectal surgery, general surgery, gynecology, hepatobiliary surgery, neurosurgery,

      obstetrics, esophagogastric surgery, ophthalmology, oral and maxillofacial surgery, orthopedics, otolaryngology, pediatric surgery, plastic surgery, thoracic surgery, transplant surgery, trauma surgery, urology, vascular surgery.

    • ●  Day case surgery and inpatient surgery is included

    • ●  Any SARS-CoV-2 status (positive at any time, negative, not tested)

    • ●  All ages including children and adults

Observational

Unspecified

Unspecified

None

Non-Randomized

N/A

Unspecified

Not Applicable

To determine the optimal timing for surgery following SARS-CoV-2 infection by comparing mortality rates between patients preoperatively infected with SARS-CoV-2, those who had an infection perioperatively, and those presumed to be unexposed at the time of surgery.

Not Applicable

Utilization Utilization Info
Publication

Timing of surgery following SARS-CoV-2 infection: an international prospective cohort study

Anaesthesia 2021,76,748–758

Oral Presentation
Drug Literature
Posters
Others
©2022 HERDIN PLUS. All rights reserved. | Contact Us | Keep up to date